Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Buy
+8,069
New +$178K ﹤0.01% 2190
2025
Q2
Sell
-13,131
Closed -$251K 2322
2025
Q1
$251K Buy
13,131
+3,928
+43% +$85.9K ﹤0.01% 1983
2024
Q4
$219K Buy
9,203
+19
+0.2% +$530 ﹤0.01% 2126
2024
Q3
$257K Sell
9,184
-427
-4% -$12.1K ﹤0.01% 2052
2024
Q2
$251K Buy
9,611
+376
+4% +$7.82K ﹤0.01% 2032
2024
Q1
$202K Buy
9,235
+600
+7% +$12.9K ﹤0.01% 2143
2023
Q4
$201K Buy
+8,635
New +$174K ﹤0.01% 2060

Other funds holding RXO

Pathstone Holdings's RXO Position: Q2 2026 in Review

Pathstone Holdings opened a new position in RXO (RXO) in Q2 2026: 8,069 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #2190 among its holdings. This is a return to the name: Pathstone Holdings previously reported a position in RXO as recently as Q1 2025.

Pathstone Holdings first reported a position in RXO in Q4 2023 and has held it in 7 quarters since. The position peaked at $257K in Q3 2024. 305 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Pathstone Holdings held 8,069 shares of RXO worth $223K as of Q2 2026.
  • RXO was a new Pathstone Holdings position in Q2 2026.
  • RXO made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2190 holding.
  • Pathstone Holdings first reported a position in RXO in Q4 2023 and has held it in 7 quarters since.
  • Pathstone Holdings's RXO position peaked at $257K in Q3 2024.
  • 305 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.